Search results
Found 378 matches for
Publications
We aim to publish our findings in leading peer-reviewed journals. Follow this page for updates.
How OxPLoreD is responding to the COVID-19 coronavirus
We are ensuring that study visits are completed in as few trips to the hospital as possible. We understand people may be feeling anxious about the risk of infection and about coming to the hospital for appointments. We at the OxPLoreD study team want to minimise the risk of exposure to the COVID-19 coronavirus for our participants. All staff working at hospital sites are abiding by government & NHS guidance during the pandemic. You will have the chance to discuss the study visits, including exactly what assessments are required and any extra precautions the site is taking with your trial team. Check back for regular updates in relation to further changes we are looking to make in response to the Covid19 coronavirus.
Information for participants
Join us and take part in the Oxford Pre-cancerous Lymphoproliferative Disorders (OxPLoreD) The study aims to understand the origins of blood and bone marrow cancers and to predict who will need treatment in future. Participants will have three study visits over five years.